Skip to header Skip to main navigation Skip to main content Skip to footer


VCU Blogs

Dr. Martin Safo, named PI on an R61 grant from NIH, “Targeted Identification of Dual Acting Antisickling Agents for Sickle Cell Disease Therapy,” totaling $575,593.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

View graphic versionView graphic version